FARMINGDALE, N.Y.--(BUSINESS WIRE)--June 8, 2006--Enzo Biochem, Inc. (NYSE:ENZ - News) today announced the appointment of Carl W. Balezentis, Ph.D. to the newly created position of President of Enzo Life Sciences, Inc. Dr. Balezentis, a senior executive with 18 years experience in the life sciences industry, was CEO of Lark Technologies, Inc., prior to its acquisition by Genaissance Pharmaceuticals, Inc.
